(´ì¤ÓµØ26¤é¥[·sªÀ¹q)±wªÌ±N§ó©ö±o¨ìÃþ¾~¤ùÂ}Å}ªvÀø¡MÁp¨¹¬F©²©Ó¿Õקïªk³W¡M®ø°£³¡¤À»Ùê¡M¥OÂå¥Í§ó©ö¦V¯f¤H¶}¥X®ü¬¥^(heroin)¤Î¬ü¨Fà¬(methadone)³B¤è¡C
§Y±N¨ì¨Óªº·sªk¨Ò±Nã³\¯f¤H¡M¦bÂå°|¥H¥~ªº¦aÂI¦pÂ}Å}¶E©Ò¡MÀò¨ú¾A·í³B¤è®ü¬¥^¡M·N¨ý¨Æ¥D±N§ó®e©ö§¡¿Å¨äªvÀø»P¤é±`¾³d¡C
¬F©²¥ç±NÅý¬ü¨Fଧó©ö¨ú±o¡M±ÂÅvÂåÅ@¤Hûñµo³B¤è¤Î¬IÃÄ¡MµL»Ý¥Ó½ÐÁp¨¹ªk«ßÁŧK¡C
½Ã¥Í³¡ªø®õ°Ç(Ginette Petitpas Taylor)©P¤@ªí¥Ü¡M®ø°£ªvÀø»Ùê¦ÜÃö«n¡M¥Øªº¬O¹K¨î¸Ó³¡§Î®eªº¥þ°ê¤½¦@ÂåÀø¦M¾÷¡M¥¦¦bÄ~Äò¦M®`®a®x»PªÀ°Ï¡C
¥[®³¤j½Ã¥Í³¡¦ôp¡M2016¦~¤j¬ù2,900¤H¦º©óÃþÃĤùÃĪ«¹L¶q¦M¾÷¡C¹w©w©P¤Gµo¥¬ªº¦ôp¼Æ¦r»¡¡M¥¦¥h¦~¹Ü¨«¹O4,000¤H©Ê©R¡C
¡mºÞ¨îÃĪ«¤Îª«½èªk¡n(Controlled Drug and Substances Act)¥Ø«e³W©w¡MÂå¥Í»Ý¥Ó½ÐÁp¨¹ªk«ßÁŧK¡M©l¯à¶}¥X¬ü¨FଳB¤è¡N¬IÃÄ¡M¥H¤Î¾P°â©Î´£¨Ñ¸ÓÃĪ«¡C
¬F©²«Å¥¬×ªk¡M±N·N¨ýÂå¥Í¤£¦A»ÝnÁŧK¡M®õ°Ç»¡¡M¥¦¬O¤@Ó»Ùê¡MªýÂZÂå¥Í´£¨ÑÀø¤è¡C
¥þ°ê6Ó¬Ù¥÷¤w¦³ã³\°õ·~Å@²z®v¶}¥X¬ü¨FଳB¤è¡M¥]¬A´µ°ª¨F¬Ù¡N¯Ã»«¤h°ì¬Ù¡N¯ÃªâÄõ¤Î©Ô¥¬©Ô¦h¬Ù¡N½q¥§¦«¤Ú¬Ù¡Nªüº¸§B¹F¬Ù»P¨õ¸Ö¬Ù¡M³o¨Ç¬Ù¥÷¤u§@ªº°õ·~Å@²z®v¡M¥¼¨Ó¤£¦A»Ýn¥Ó½ÐÁp¨¹ÁŧK¡C
·sªk®Æ©ó5¤ë¨ì¦ì¡Ml¥Í¦Û¡u¥[®³¤jÀÝÃĬã¨s¶µ¥Ø¡v(Canadian Research Initiative in Substances Misuse)¤ëªìµoªíªº«ü¤Þ¡C
43¦WÂåÀø¤Hû²Õ¦¨ªººôµ¸¡M¨îq¤@®M·sªº¥[®³¤j«ü¤Þ¡M´£¥X¦p¦óºÞ²zÃþ¾~¤ùÃĨϥΰÝÃDªº«Øij¡M¥]¬A¨Ï¥Î¦óºØ´À¥NÃĪ«ªvÀøÂ}Å}¡C¨ä¤¤¦³«ØijÃþ¾~¤ùÃĪ«ªº´À¥N«~µÎ¿¥Í(Suboxone)¡M¥¦³Q»{¬°¤ñ¬ü¨Fଧó¦w¥þ¡MÀ³¸Ó¬O¥Î¨ÓªvÀø±j¯P³Â¾KÃĦ¨Â}¯f¤Hªºº¿ï¡C